Phaedrus

[SuperAlerts] I could use a second opinion on $EXEL, it's a potential short squeeze biotech candidate. Over 30% shares sold short because of a bad result back in October, last Thursday they had a drug fast-tracked by the FDA. They also have a few more drugs in the pipeline.

Phaedrus

[SuperAlerts] $AMCO is crazy cheap right now. Their current assets are capable of paying off all short term and long term liabilities

Page
of 3